Prognosis
South Africa Has Concerns About Sputnik V, Novavax Vaccines
This article is for subscribers only.
South Africa has held extensive talks with the manufacturers of Russia’s Sputnik V vaccine and has concerns about its efficacy against a variant of the coronavirus first identified in the country, a government official said.
The country is also concerned about the adenovirus 5 vector used in the shot, which has in previous studies appeared to make people more susceptible to HIV infection, Anban Pillay, deputy director-general in the department of health, said on a webinar on Tuesday.